Scleroderma

Light micrograph of a vascular lesion (center) caused by systemic sclerosis.

Case Report: Can Salt-&-Pepper Skin Mean Systemic Sclerosis?

September 17, 2019 • By Wesam Gouda, MBBCh, MSc; Abdelhafeez Moshrif, MBBCh, MSc, MD; Fatma H. El Nouby, MBBCh, MSc, MD; & Amal Fehr, MBBCh, MSc, MD

Study Probes New Gene Therapy for Severe, Localized Scleroderma (Morphea)

August 16, 2019 • By Ruth Jessen Hickman, MD

New Studies Identify Possible Markers of Early Systemic Sclerosis

August 16, 2019 • By Bryn Nelson, PhD

Lessons Learned from Two Scleroderma Lung Studies (Plus a Third That’s Recruiting Sites)

August 16, 2019 • By Elizabeth R. Volkmann, MD, MS, Michael D. Roth, MD, Donald P. Tashkin, MD, Cathie Spino, ScD, & Dinesh Khanna, MD, MS

Recent Trials Investigated Targeted Therapies for Systemic Sclerosis

May 18, 2019 • By Mary Beth Nierengarten

Markers for Severe Gastrointestinal Dysmotility in Systemic Sclerosis

May 18, 2019 • By Larry Beresford

The Little-Known (But Not Uncommon) SSc-Lupus Overlap Syndrome

May 18, 2019 • By Susan Bernstein

A Case of Eosinophilic Fasciitis Presenting with Pansclerotic Morphea

May 17, 2019 • By Julia K. Munchel, MD, & William E. Monaco, MD

Living Well with Scleroderma

March 19, 2019 • By Lara C. Pullen, PhD

Scleroderma Autoantibodies Linked to Cancer Risk

November 18, 2018 • By Kurt Ullman